论文部分内容阅读
大剂量皮质类固醇(以下简称 CS)疗法作为成人呼吸窘迫综合征(ARDS)的辅助疗法己受到人们的赞同。本文以静脉注射~(131)I 人血清白蛋白(I-HSA)方法,观察 CS 治疗前后支气管-肺泡分泌物中 I-HSM 含量(γ-闪烁计数器计量),借以探讨药理剂量 CS 对人类败血症性 ARDS 肺泡-毛细血管通透性的影响。受试者共19例,分为两组:组1(14例),9例接受6-甲强的松龙治疗30mg/kg;5例接受氟美松治疗4mg/kg。组2(5例)只接受6-甲强
High-dose corticosteroids (hereinafter referred to as CS) therapies as adjuvant therapy for adult respiratory distress syndrome (ARDS) have been the people’s approval. In this paper, the content of I-HSM in bronchoalveolar secretions before and after CS treatment (γ-scintillation counting) was measured by intravenous injection of ~ (131) I human serum albumin (I-HSA) to explore the effect of CS on human sepsis Effect of ARDS alveolar-capillary permeability. A total of 19 subjects were divided into two groups: Group 1 (n = 14), 9 received 30 mg / kg of 6-methylprednisolone, and 5 received 4 mg / kg of dexamethasone. Group 2 (5 cases) only received 6-A strong